{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:11:56Z","timestamp":1788361916118,"version":"build-2803163510"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10290-z","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:41:06Z","timestamp":1739454066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Review of mesenchymal stem cell-derived exosomes and their potential therapeutic roles in treating rheumatoid arthritis"],"prefix":"10.1007","volume":"52","author":[{"given":"S.","family":"Aghajani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Maboudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Seyhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Rahim","family":"Nia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Namazi","family":"Shabestari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sh","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Daneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Verdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"10290_CR1","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3390\/cells10113017","volume":"10","author":"A-L Mueller","year":"2021","unstructured":"Mueller A-L, Payandeh Z, Mohammadkhani N, Mubarak SM, Zakeri A, Alagheband Bahrami A, Brockmueller A, Shakibaei M (2021) Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies. Cells 10:3017","journal-title":"Cells"},{"key":"10290_CR2","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang J, Fu X, Chen X, Li Z, Huang Y, Liang C (2021) Promising therapeutic targets for treatment of rheumatoid arthritis. Front Immunol 12:686155","journal-title":"Front Immunol"},{"key":"10290_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.semarthrit.2019.10.005","volume":"50","author":"D Di","year":"2020","unstructured":"Di D, Zhang L, Wu X, Leng R (2020) Long-term exposure to outdoor air pollution and the risk of development of rheumatoid arthritis: a systematic review and meta-analysis. Seminars Arthritis Rheumatism 50:266\u2013275","journal-title":"Seminars Arthritis Rheumatism"},{"key":"10290_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2023.104771","author":"S Dehnavi","year":"2023","unstructured":"Dehnavi S, Sadeghi M, Afshari JT, Mohammadi M (2023) Interactions of mesenchymal stromal\/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis. Cell Immunol. https:\/\/doi.org\/10.1016\/j.cellimm.2023.104771","journal-title":"Cell Immunol"},{"key":"10290_CR5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2019","unstructured":"Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J (2019) Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract 27:501\u2013507","journal-title":"Med Princ Pract"},{"key":"10290_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1566523220666200916120708","volume":"20","author":"F Tavasolian","year":"2020","unstructured":"Tavasolian F, Hosseini AZ, Soudi S, Naderi M (2020) miRNA-146a improves immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis. Curr Gene Ther 20:297\u2013312","journal-title":"Curr Gene Ther"},{"key":"10290_CR7","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cells9081852","volume":"9","author":"M Lopez-Santalla","year":"2020","unstructured":"Lopez-Santalla M, Fernandez-Perez R, Garin MI (2020) Mesenchymal stem\/stromal cells for rheumatoid arthritis treatment: an update on clinical applications. Cells 9:1852","journal-title":"Cells"},{"key":"10290_CR8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/ijms24021337","volume":"24","author":"SV Krylova","year":"2023","unstructured":"Krylova SV, Feng D (2023) The machinery of exosomes: biogenesis, release, and uptake. Int J Mol Sci 24:1337","journal-title":"Int J Mol Sci"},{"key":"10290_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","volume":"20","author":"J Rezaie","year":"2022","unstructured":"Rezaie J, Feghhi M, Etemadi T (2022) A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal 20:145","journal-title":"Cell Commun Signal"},{"key":"10290_CR10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1096\/fba.2020-00127","volume":"3","author":"JW Clancy","year":"2021","unstructured":"Clancy JW, Schmidtmann M, D\u2019Souza-Schorey C (2021) The ins and outs of microvesicles. FASEB BioAdvances 3:399","journal-title":"FASEB BioAdvances"},{"key":"10290_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-030-67171-6_4","volume":"97","author":"JP Santavanond","year":"2021","unstructured":"Santavanond JP, Rutter SF, Atkin-Smith GK, Poon IK (2021) Apoptotic bodies: mechanism of formation, isolation and functional relevance. Subcell Biochem 97:61\u201388","journal-title":"Subcell Biochem"},{"key":"10290_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/biology9010021","volume":"9","author":"M Battistelli","year":"2021","unstructured":"Battistelli M, Falcieri E (2021) Apoptotic bodies: particular extracellular vesicles involved in intercellular communication. Biology 9:21","journal-title":"Biology"},{"key":"10290_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","volume":"23","author":"EI Buzas","year":"2023","unstructured":"Buzas EI (2023) The roles of extracellular vesicles in the immune system. Nat Rev Immunol 23:236\u2013250","journal-title":"Nat Rev Immunol"},{"key":"10290_CR14","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41375-020-01041-z","volume":"34","author":"MZ Ratajczak","year":"2020","unstructured":"Ratajczak MZ, Ratajczak J (2020) Extracellular microvesicles\/exosomes: discovery, disbelief, acceptance, and the future? Leukemia 34:3126\u20133135","journal-title":"Leukemia"},{"key":"10290_CR15","volume":"207","author":"M Li","year":"2020","unstructured":"Li M, Li S, Du C, Zhang Y, Li Y, Chu L, Han X, Galons H, Zhang Y, Sun H (2020) Exosomes from different cells: Characteristics, modifications, and therapeutic applications. Eur J Med Chem 207:112784","journal-title":"Eur J Med Chem"},{"key":"10290_CR16","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.3390\/ijms21186646","volume":"21","author":"S Sedykh","year":"2020","unstructured":"Sedykh S, Kuleshova A, Nevinsky G (2020) Milk exosomes: Perspective agents for anticancer drug delivery. Int J Mol Sci 21:6646","journal-title":"Int J Mol Sci"},{"key":"10290_CR17","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.7150\/thno.97096","volume":"14","author":"B Zhao","year":"2024","unstructured":"Zhao B, Lin H, Jiang X, Li W, Gao Y, Li M, Yu Y, Chen N, Gao J (2024) Exosome-like nanoparticles derived from fruits, vegetables, and herbs: Innovative strategies of therapeutic and drug delivery. Theranostics 14:4598","journal-title":"Theranostics"},{"key":"10290_CR18","volume":"20","author":"S Fu","year":"2020","unstructured":"Fu S, Wang Y, Xia X, Zheng JC (2020) Exosome engineering: Current progress in cargo loading and targeted delivery. NanoImpact 20:100261","journal-title":"NanoImpact"},{"key":"10290_CR19","first-page":"407","volume-title":"Applications of exosomes in nanomedicine","author":"AH Souderjani","year":"2023","unstructured":"Souderjani AH, Rahimi F, Amoabediny G, Didandeh M, Montazeri M (2023) Applications of exosomes in nanomedicine. Elsevier, Nanomedicine, pp 407\u2013414"},{"key":"10290_CR20","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.3390\/ijms23169178","volume":"23","author":"A Pavlic","year":"2022","unstructured":"Pavlic A, Bahram Sangani N, Kerins J, Nicolaes G, Schurgers L, Reutelingsperger C (2022) Vascular smooth muscle cell neutral sphingomyelinase 2 in the release of exosomes and vascular calcification. Int J Mol Sci 23:9178","journal-title":"Int J Mol Sci"},{"key":"10290_CR21","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.259324","author":"D Choezom","year":"2022","unstructured":"Choezom D, Gross JC (2022) Neutral sphingomyelinase 2 controls exosome secretion by counteracting V-ATPase-mediated endosome acidification. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.259324","journal-title":"J Cell Sci"},{"key":"10290_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"Q-F Han","year":"2022","unstructured":"Han Q-F, Li W-J, Hu K-S, Gao J, Zhai W-L, Yang J-H, Zhang S-J (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21:207","journal-title":"Mol Cancer"},{"key":"10290_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 19:47","journal-title":"Cell Commun Signal"},{"key":"10290_CR24","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M, Ji J, Jin D, Wu Y, Wu T, Lin R, Zhu S, Jiang F, Ji Y, Bao B (2023) The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases. Genes Diseases 10:1894\u20131907","journal-title":"Genes Diseases"},{"key":"10290_CR25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","volume":"34","author":"SB Arya","year":"2024","unstructured":"Arya SB, Collie SP, Parent CA (2024) The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol 34:90\u2013108","journal-title":"Trends Cell Biol"},{"key":"10290_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-020-03703-z","volume":"467","author":"AS Jadli","year":"2020","unstructured":"Jadli AS, Ballasy N, Edalat P, Patel VB (2020) Inside (sight) of tiny communicator: exosome biogenesis, secretion, and uptake. Mol Cell Biochem 467:77\u201394","journal-title":"Mol Cell Biochem"},{"key":"10290_CR27","doi-asserted-by":"crossref","first-page":"12356","DOI":"10.1002\/jev2.12356","volume":"12","author":"C Liu","year":"2023","unstructured":"Liu C, Liu D, Wang S, Gan L, Yang X, Ma C (2023) Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion. J Extracellular Vesicles 12:12356","journal-title":"J Extracellular Vesicles"},{"key":"10290_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105835","author":"M Dowaidar","year":"2024","unstructured":"Dowaidar M (2024) Drug delivery based exosomes uptake pathways. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2024.105835","journal-title":"Neurochem Int"},{"key":"10290_CR29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jconrel.2020.07.042","volume":"326","author":"S Salunkhe","year":"2020","unstructured":"Salunkhe S, Basak M, Chitkara D, Mittal A (2020) Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance. J Control Release 326:599\u2013614","journal-title":"J Control Release"},{"key":"10290_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2023.05.002","volume":"73","author":"L Ye","year":"2023","unstructured":"Ye L, Li Y, Zhang S, Wang J, Lei B (2023) Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression. Cytokine Growth Factor Rev 73:27\u201339","journal-title":"Cytokine Growth Factor Rev"},{"key":"10290_CR31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S1431927620000070","volume":"26","author":"J-H Deng","year":"2020","unstructured":"Deng J-H, Li Z-J, Wang Z-X, Feng J, Huang X-J, Zeng Z-M (2020) Electron microscopy-based comparison and investigation of the morphology of exosomes derived from hepatocellular carcinoma cells isolated at different centrifugal speeds. Microsc Microanal 26:310\u2013318","journal-title":"Microsc Microanal"},{"key":"10290_CR32","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.3390\/ijms241310477","volume":"24","author":"REM Qazi","year":"2023","unstructured":"Qazi REM, Sajid Z, Zhao C, Hussain I, Iftikhar F, Jameel M, Rehman FU, Mian AA (2023) Lyophilization based isolation of exosomes. Int J Mol Sci 24:10477","journal-title":"Int J Mol Sci"},{"key":"10290_CR33","doi-asserted-by":"crossref","unstructured":"D. Bagrov, A. Senkovenko, I. Nikishin, G. Skryabin, P. Kopnin, E. Tchevkina, Application of AFM, TEM, and NTA for characterization of exosomes produced by placenta-derived mesenchymal cells, Journal of Physics: Conference Series, IOP Publishing, 2021, pp. 012013.","DOI":"10.1088\/1742-6596\/1942\/1\/012013"},{"key":"10290_CR34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12017-021-08696-6","volume":"24","author":"G Yousif","year":"2022","unstructured":"Yousif G, Qadri S, Parray A, Akhthar N, Shuaib A, Haik Y (2022) Exosomes derived neuronal markers: immunoaffinity isolation and characterization. Neuromol Med 24:339","journal-title":"Neuromol Med"},{"key":"10290_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301706","author":"KHW Yim","year":"2023","unstructured":"Yim KHW, Krzyzaniak O, Al Hrout AA, Peacock B, Chahwan R (2023) Assessing extracellular vesicles in human biofluids using flow-based analyzers. Adv Healthcare Mater. https:\/\/doi.org\/10.1002\/adhm.202301706","journal-title":"Adv Healthcare Mater"},{"key":"10290_CR36","doi-asserted-by":"crossref","first-page":"32945","DOI":"10.3402\/jev.v5.32945","volume":"5","author":"C Gardiner","year":"2016","unstructured":"Gardiner C, Vizio DD, Sahoo S, Th\u00e9ry C, Witwer KW, Wauben M, Hill AF (2016) Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracellular Vesicles 5:32945","journal-title":"J Extracellular Vesicles"},{"key":"10290_CR37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jth.13190","volume":"14","author":"E Van der Pol","year":"2016","unstructured":"Van der Pol E, B\u00f6ing A, Gool E, Nieuwland R (2016) Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J Thromb Haemost 14:48\u201356","journal-title":"J Thromb Haemost"},{"key":"10290_CR38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-0716-1186-9_9","volume":"2261","author":"A Rai","year":"2021","unstructured":"Rai A, Fang H, Fatmous M, Claridge B, Poh QH, Simpson RJ, Greening DW (2021) A protocol for isolation, purification, characterization, and functional dissection of exosomes. Proteomic Profiling: Methods Protocols 2261:105\u2013149","journal-title":"Proteomic Profiling: Methods Protocols"},{"key":"10290_CR39","volume":"8","author":"D Zheng","year":"2021","unstructured":"Zheng D, Huo M, Li B, Wang W, Piao H, Wang Y, Zhu Z, Li D, Wang T, Liu K (2021) The role of exosomes and exosomal microRNA in cardiovascular disease. Front Cell Develop Biol 8:616161","journal-title":"Front Cell Develop Biol"},{"key":"10290_CR40","first-page":"1390","volume":"54","author":"X Wang","year":"2022","unstructured":"Wang X, Huang J, Chen W, Li G, Li Z, Lei J (2022) The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer. Exp Mol Med 54:1390\u20131400","journal-title":"Exp Mol Med"},{"key":"10290_CR41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s11658-022-00384-y","volume":"27","author":"AT Gharavi","year":"2022","unstructured":"Gharavi AT, Hanjani NA, Movahed E, Doroudian M (2022) The role of macrophage subtypes and exosomes in immunomodulation. Cell Mol Biol Lett 27:83","journal-title":"Cell Mol Biol Lett"},{"key":"10290_CR42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.15558","volume":"288","author":"FG Kugeratski","year":"2021","unstructured":"Kugeratski FG, Kalluri R (2021) Exosomes as mediators of immune regulation and immunotherapy in cancer. FEBS J 288:10\u201335","journal-title":"FEBS J"},{"key":"10290_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science. https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"key":"10290_CR44","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Ren L, Li S, Li W, Zheng X, Yang Y, Fu W, Yi J, Wang J, Du G (2021) The biology, function, and applications of exosomes in cancer. Acta Pharmaceutica Sinica B 11:2783\u20132797","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10290_CR45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41419-020-03189-z","volume":"11","author":"X Dong","year":"2020","unstructured":"Dong X, Bai X, Ni J, Zhang H, Duan W, Graham P, Li Y (2020) Exosomes and breast cancer drug resistance. Cell Death Dis 11:987","journal-title":"Cell Death Dis"},{"key":"10290_CR46","volume":"14","author":"M Guo","year":"2021","unstructured":"Guo M, Hao Y, Feng Y, Li H, Mao Y, Dong Q, Cui M (2021) Microglial exosomes in neurodegenerative disease. Front Mol Neurosci 14:630808","journal-title":"Front Mol Neurosci"},{"key":"10290_CR47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/biomedicines9081061","volume":"9","author":"MI Mosquera-Heredia","year":"2021","unstructured":"Mosquera-Heredia MI, Morales LC, Vidal OM, Barcelo E, Silvera-Redondo C, V\u00e9lez JI, Garavito-Galofre P (2021) Exosomes: potential disease biomarkers and new therapeutic targets. Biomedicines 9:1061","journal-title":"Biomedicines"},{"key":"10290_CR48","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1038\/s41598-020-70393-4","volume":"10","author":"Y Risha","year":"2020","unstructured":"Risha Y, Minic Z, Ghobadloo SM, Berezovski MV (2020) The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers. Sci Rep 10:13572","journal-title":"Sci Rep"},{"key":"10290_CR49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12967-022-03493-6","volume":"20","author":"Y Fan","year":"2022","unstructured":"Fan Y, Chen Z, Zhang M (2022) Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases. J Transl Med 20:291","journal-title":"J Transl Med"},{"key":"10290_CR50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-019-0963-9","volume":"18","author":"KM McAndrews","year":"2019","unstructured":"McAndrews KM, Kalluri R (2019) Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer 18:52","journal-title":"Mol Cancer"},{"key":"10290_CR51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41389-022-00431-5","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Tian L, Lu J, Ng IO-L (2022) Exosomes and cancer-Diagnostic and prognostic biomarkers and therapeutic vehicle. Oncogenesis 11:54","journal-title":"Oncogenesis"},{"key":"10290_CR52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2020.07.026","volume":"154","author":"SM Patil","year":"2020","unstructured":"Patil SM, Sawant SS, Kunda NK (2020) Exosomes as drug delivery systems: A brief overview and progress update. Eur J Pharm Biopharm 154:259\u2013269","journal-title":"Eur J Pharm Biopharm"},{"key":"10290_CR53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fphar.2017.00300","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Sun X, Zhao J, Yang Y, Cai X, Xu J, Cao P (2017) Exosomes: a novel strategy for treatment and prevention of diseases. Front Pharmacol 8:300","journal-title":"Front Pharmacol"},{"key":"10290_CR54","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/cancers12030661","volume":"12","author":"AL Di Pace","year":"2020","unstructured":"Di Pace AL, Tumino N, Besi F, Alicata C, Conti LA, Munari E, Maggi E, Vacca P, Moretta L (2020) Characterization of human NK cell-derived exosomes: role of DNAM1 receptor in exosome-mediated cytotoxicity against the tumor. Cancers 12:661","journal-title":"Cancers"},{"key":"10290_CR55","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101771","volume":"49","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Pandya A, Kumar L, Raval N, Vora LK, Pulakkat S, Patravale V, Duo Y, Tang BZ (2023) Exosome nanovesicles: a potential carrier for therapeutic delivery. Nano Today 49:101771","journal-title":"Nano Today"},{"key":"10290_CR56","doi-asserted-by":"crossref","unstructured":"B.J. Crenshaw, B. Sims, Q.L. Matthews, Biological function of exosomes as diagnostic markers and therapeutic delivery vehicles in carcinogenesis and infectious diseases, Nanomedicines, IntechOpen London, UK2018, pp. 1\u201332.","DOI":"10.5772\/intechopen.80225"},{"key":"10290_CR57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo J-K, Choi C (2021) Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regenerative Med 18:499\u2013511","journal-title":"Tissue Eng Regenerative Med"},{"key":"10290_CR58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7150\/thno.38198","volume":"10","author":"Z Wan","year":"2020","unstructured":"Wan Z, Zhao L, Lu F, Gao X, Dong Y, Zhao Y, Wei M, Yang G, Xing C, Liu L (2020) Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics 10:218","journal-title":"Theranostics"},{"key":"10290_CR59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1567201817666200122163251","volume":"17","author":"X Zhou","year":"2020","unstructured":"Zhou X, Li Z, Sun W, Yang G, Xing C, Yuan L (2020) Delivery efficacy differences of intravenous and intraperitoneal injection of exosomes: Perspectives from tracking dye-labeled and MiRNA encapsulated exosomes. Curr Drug Deliv 17:186\u2013194","journal-title":"Curr Drug Deliv"},{"key":"10290_CR60","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsnano.1c08473","volume":"16","author":"H Peng","year":"2022","unstructured":"Peng H, Li Y, Ji W, Zhao R, Lu Z, Shen J, Wu Y, Wang J, Hao Q, Wang J (2022) Intranasal administration of self-oriented nanocarriers based on therapeutic exosomes for synergistic treatment of Parkinson\u2019s disease. ACS Nano 16:869\u2013884","journal-title":"ACS Nano"},{"key":"10290_CR61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121126","volume":"277","author":"J Zhong","year":"2021","unstructured":"Zhong J, Xia B, Shan S, Zheng A, Zhang S, Chen J, Liang X-J (2021) High-quality milk exosomes as oral drug delivery system. Biomaterials 277:121126","journal-title":"Biomaterials"},{"key":"10290_CR62","first-page":"1222","volume":"25","author":"E Fathi","year":"2022","unstructured":"Fathi E, Mesbah-Namin SA, Vietor I, Farahzadi R (2022) Mesenchymal stem cells cause induction of granulocyte differentiation of rat bone marrow C-kit+ hematopoietic stem cells through JAK3\/STAT3, ERK, and PI3K signaling pathways. Iran J Basic Med Sci 25:1222","journal-title":"Iran J Basic Med Sci"},{"key":"10290_CR63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s12276-023-01149-z","volume":"56","author":"G Bhattarai","year":"2024","unstructured":"Bhattarai G, Shrestha SK, Sim H-J, Lee J-C, Kook S-H (2024) Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic review. Exp Mol Med 56:118\u2013128","journal-title":"Exp Mol Med"},{"key":"10290_CR64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13287-021-02138-7","volume":"12","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zhou Y, Li H-J (2021) Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther 12:71","journal-title":"Stem Cell Res Ther"},{"key":"10290_CR65","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, Hua D, Shao C, Shi Y (2022) The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther 7:92","journal-title":"Signal Transduct Target Ther"},{"key":"10290_CR66","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2021.151713","volume":"123","author":"E Vinod","year":"2021","unstructured":"Vinod E, Parameswaran R, Amirtham SM, Rebekah G, Kachroo U (2021) Comparative analysis of human bone marrow mesenchymal stem cells, articular cartilage derived chondroprogenitors and chondrocytes to determine cell superiority for cartilage regeneration. Acta Histochem 123:151713","journal-title":"Acta Histochem"},{"key":"10290_CR67","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118002","volume":"256","author":"M Maqsood","year":"2020","unstructured":"Maqsood M, Kang M, Wu X, Chen J, Teng L, Qiu L (2020) Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine. Life Sci 256:118002","journal-title":"Life Sci"},{"key":"10290_CR68","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3390\/biomedicines10123112","volume":"10","author":"F Santilli","year":"2022","unstructured":"Santilli F, Fabrizi J, Pulcini F, Santacroce C, Sorice M, Delle Monache S, Mattei V (2022) Gangliosides and their role in multilineage differentiation of mesenchymal stem cells. Biomedicines 10:3112","journal-title":"Biomedicines"},{"key":"10290_CR69","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.3390\/ijms231710023","volume":"23","author":"Y Huang","year":"2022","unstructured":"Huang Y, Wu Q, Tam PKH (2022) Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci 23:10023","journal-title":"Int J Mol Sci"},{"key":"10290_CR70","volume":"9","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller L, Tunger A, Wobus M, von Bonin M, Towers R, Bornh\u00e4user M, Dazzi F, Wehner R, Schmitz M (2021) Immunomodulatory properties of mesenchymal stromal cells: an update. Front Cell Develop Biol 9:637725","journal-title":"Front Cell Develop Biol"},{"key":"10290_CR71","volume":"12","author":"Z Shen","year":"2021","unstructured":"Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K (2021) Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol 12:749192","journal-title":"Front Immunol"},{"key":"10290_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02265-1","volume":"12","author":"A Markov","year":"2021","unstructured":"Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A (2021) Mesenchymal stem\/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 12:1\u201330","journal-title":"Stem Cell Res Ther"},{"key":"10290_CR73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/cells10010054","volume":"10","author":"J Vasanthan","year":"2020","unstructured":"Vasanthan J, Gurusamy N, Rajasingh S, Sigamani V, Kirankumar S, Thomas EL, Rajasingh J (2020) Role of human mesenchymal stem cells in regenerative therapy. Cells 10:54","journal-title":"Cells"},{"key":"10290_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1471-y","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Shen H, Shao L, Teng X, Chen Y, Liu X, Yang Z, Shen Z (2020) HIF-1\u03b1 overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis. Stem Cell Res Ther 11:1\u201313","journal-title":"Stem Cell Res Ther"},{"key":"10290_CR75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10529-020-02831-2","volume":"42","author":"R Zhang","year":"2020","unstructured":"Zhang R, Zhu Y, Li Y, Liu W, Yin L, Yin S, Ji C, Hu Y, Wang Q, Zhou X (2020) Human umbilical cord mesenchymal stem cell exosomes alleviate sepsis-associated acute kidney injury via regulating microRNA-146b expression. Biotech Lett 42:669\u2013679","journal-title":"Biotech Lett"},{"key":"10290_CR76","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/cells9030680","volume":"9","author":"K-O Shin","year":"2020","unstructured":"Shin K-O, Ha DH, Kim JO, Crumrine DA, Meyer JM, Wakefield JS, Lee Y, Kim B, Kim S, Kim H-K (2020) Exosomes from human adipose tissue-derived mesenchymal stem cells promote epidermal barrier repair by inducing de novo synthesis of ceramides in atopic dermatitis. Cells 9:680","journal-title":"Cells"},{"key":"10290_CR77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biomaterials.2017.04.030","volume":"133","author":"W Du","year":"2017","unstructured":"Du W, Zhang K, Zhang S, Wang R, Nie Y, Tao H, Han Z, Liang L, Wang D, Liu J (2017) Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer. Biomaterials 133:70\u201381","journal-title":"Biomaterials"},{"key":"10290_CR78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113943","volume":"156","author":"A Hazrati","year":"2022","unstructured":"Hazrati A, Malekpour K, Soudi S, Hashemi SM (2022) CRISPR\/Cas9-engineered mesenchymal stromal\/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations. Biomed Pharmacother 156:113943","journal-title":"Biomed Pharmacother"},{"key":"10290_CR79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jare.2022.01.013","volume":"41","author":"SP Cam\u00f5es","year":"2022","unstructured":"Cam\u00f5es SP, Bulut O, Yazar V, Gaspar MM, Sim\u00f5es S, Ferreira R, Vitorino R, Santos JM, Gursel I, Miranda JP (2022) 3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution. J Adv Res 41:113\u2013128","journal-title":"J Adv Res"},{"key":"10290_CR80","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/jcm8050626","volume":"8","author":"M Najar","year":"2019","unstructured":"Najar M, Bouhtit F, Melki R, Afif H, Hamal A, Fahmi H, Merimi M, Lagneaux L (2019) Mesenchymal stromal cell-based therapy: new perspectives and challenges. J Clin Med 8:626","journal-title":"J Clin Med"},{"key":"10290_CR81","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102735","volume":"20","author":"A Conforti","year":"2021","unstructured":"Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, Giacomelli R, Cipriani P (2021) Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev 20:102735","journal-title":"Autoimmun Rev"},{"key":"10290_CR82","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/all.15889","volume":"78","author":"M Jutel","year":"2023","unstructured":"Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, Del Giacco S, Gajdanowicz P, Gracia IE, Klimek L, Lauerma A (2023) Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper. Allergy 78:2851\u20132874","journal-title":"Allergy"},{"key":"10290_CR83","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13287-023-03473-7","volume":"14","author":"M Babaahmadi","year":"2023","unstructured":"Babaahmadi M, Tayebi B, Gholipour NM, Kamardi MT, Heidari S, Baharvand H, Eslaminejad MB, Hajizadeh-Saffar E, Hassani S-N (2023) Rheumatoid arthritis: the old issue, the new therapeutic approach. Stem Cell Res Ther 14:268","journal-title":"Stem Cell Res Ther"},{"key":"10290_CR84","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3899\/jrheum.200367","volume":"48","author":"KB Almutairi","year":"2021","unstructured":"Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA (2021) The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol 48:669\u2013676","journal-title":"J Rheumatol"},{"key":"10290_CR85","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","volume":"314","author":"AS Doghish","year":"2023","unstructured":"Doghish AS, Ismail A, El-Mahdy HA, Elkhawaga SY, Elsakka EG, Mady EA, Elrebehy MA, Khalil MA, El-Husseiny HM (2023) miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers. Life Sci 314:121321","journal-title":"Life Sci"},{"key":"10290_CR86","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.689698","volume":"8","author":"VC Rom\u00e3o","year":"2021","unstructured":"Rom\u00e3o VC, Fonseca JE (2021) Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review. Front Med 8:689698","journal-title":"Front Med"},{"key":"10290_CR87","volume":"93","author":"Z Wu","year":"2021","unstructured":"Wu Z, Ma D, Yang H, Gao J, Zhang G, Xu K, Zhang L (2021) Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes. Int Immunopharmacol 93:107392","journal-title":"Int Immunopharmacol"},{"key":"10290_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13317-020-00145-x","volume":"12","author":"MJ Mousavi","year":"2021","unstructured":"Mousavi MJ, Karami J, Aslani S, Tahmasebi MN, Vaziri AS, Jamshidi A, Farhadi E, Mahmoudi M (2021) Transformation of fibroblast-like synoviocytes in rheumatoid arthritis; from a friend to foe. Autoimmunity Highlights 12:1\u201313","journal-title":"Autoimmunity Highlights"},{"key":"10290_CR89","volume":"13","author":"DE Mahmoud","year":"2022","unstructured":"Mahmoud DE, Kaabachi W, Sassi N, Tarhouni L, Rekik S, Jemmali S, Sehli H, Kallel-Sellami M, Cheour E, Laadhar L (2022) The synovial fluid fibroblast-like synoviocyte: A long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis. Front Immunol 13:942417","journal-title":"Front Immunol"},{"key":"10290_CR90","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","volume":"6","author":"C Li","year":"2021","unstructured":"Li C, Ni Y-Q, Xu H, Xiang Q-Y, Zhao Y, Zhan J-K, He J-Y, Li S, Liu Y-S (2021) Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther 6:383","journal-title":"Signal Transduct Target Ther"},{"key":"10290_CR91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/15476286.2020.1857941","volume":"18","author":"J Chen","year":"2021","unstructured":"Chen J, Luo X, Liu M, Peng L, Zhao Z, He C, He Y (2021) Silencing long non-coding RNA NEAT1 attenuates rheumatoid arthritis via the MAPK\/ERK signalling pathway by downregulating microRNA-129 and microRNA-204. RNA Biol 18:657\u2013668","journal-title":"RNA Biol"},{"key":"10290_CR92","volume":"8","author":"Y Rao","year":"2020","unstructured":"Rao Y, Fang Y, Tan W, Liu D, Pang Y, Wu X, Zhang C, Li G (2020) Delivery of long non-coding RNA NEAT1 by peripheral blood monouclear cells-derived exosomes promotes the occurrence of rheumatoid arthritis via the MicroRNA-23a\/MDM2\/SIRT6 axis. Front Cell Develop Biol 8:551681","journal-title":"Front Cell Develop Biol"},{"key":"10290_CR93","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jir.2018.0117","volume":"39","author":"OG Shaker","year":"2019","unstructured":"Shaker OG, Mahmoud RH, Abdelaleem OO, Ahmed TI, Fouad NA, Hussein HA, Nassr MH, Zaki OM, Abdelghaffar NK, Hefzy EM (2019) Expression profile of long noncoding RNAs, lnc-Cox2, and HOTAIR in rheumatoid arthritis patients. J Interferon Cytokine Res 39:174\u2013180","journal-title":"J Interferon Cytokine Res"},{"key":"10290_CR94","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106549","volume":"186","author":"J Yang","year":"2022","unstructured":"Yang J, Li Z, Wang L, Yun X, Zeng Y, Ng JP, Lo H, Wang Y, Zhang K, Law BYK (2022) The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis. Pharmacol Res 186:106549","journal-title":"Pharmacol Res"},{"key":"10290_CR95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10238-013-0271-4","volume":"15","author":"J Song","year":"2015","unstructured":"Song J, Kim D, Han J, Kim Y, Lee M, Jin E-J (2015) PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med 15:121\u2013126","journal-title":"Clin Exp Med"},{"key":"10290_CR96","volume":"409","author":"X Yao","year":"2021","unstructured":"Yao X, Wang Q, Zeng P, Hou L, Yang Y, Lu D, Huang Y, Ning Q, Xu H, Cao Y (2021) LncRNA HOTTIP from synovial fibroblast-derived exosomes: a novel molecular target for rheumatoid arthritis through the miR-1908\u20135p\/STAT3 axis. Exp Cell Res 409:112943","journal-title":"Exp Cell Res"},{"key":"10290_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-020-02056-z","volume":"16","author":"Y Su","year":"2021","unstructured":"Su Y, Liu Y, Ma C, Guan C, Ma X, Meng S (2021) Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p\/TNFAIP3\/NF-\u03baB pathway. J Orthop Surg Res 16:1\u201314","journal-title":"J Orthop Surg Res"},{"key":"10290_CR98","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E (2022) Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 38:613\u2013626","journal-title":"Trends Genet"},{"key":"10290_CR99","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/art.23429","volume":"58","author":"T Nakasa","year":"2008","unstructured":"Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, Ochi M, Asahara H (2008) Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 58:1284\u20131292","journal-title":"Arthritis Rheum"},{"key":"10290_CR100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10495-018-1474-7","volume":"23","author":"J Gao","year":"2018","unstructured":"Gao J, Kong R, Zhou X, Ji L, Zhang J, Zhao D (2018) MiRNA-126 expression inhibits IL-23R mediated TNF-\u03b1 or IFN-\u03b3 production in fibroblast-like synoviocytes in a mice model of collagen-induced rheumatoid arthritis. Apoptosis 23:607\u2013615","journal-title":"Apoptosis"},{"key":"10290_CR101","doi-asserted-by":"crossref","first-page":"9607946","DOI":"10.1155\/2016\/9607946","volume":"2016","author":"M Ciechomska","year":"2016","unstructured":"Ciechomska M, O\u2019Reilly S (2016) Epigenetic modulation as a therapeutic prospect for treatment of autoimmune rheumatic diseases. Mediators Inflamm 2016:9607946","journal-title":"Mediators Inflamm"},{"key":"10290_CR102","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/jcmm.12353","volume":"18","author":"L Dong","year":"2014","unstructured":"Dong L, Wang X, Tan J, Li H, Qian W, Chen J, Chen Q, Wang J, Xu W, Tao C (2014) Decreased expression of micro RNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med 18:2213\u20132224","journal-title":"J Cell Mol Med"},{"key":"10290_CR103","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","volume":"478","author":"P Prasad","year":"2023","unstructured":"Prasad P, Verma S, Surbhi NK, Ganguly V, Chaturvedi SAM (2023) Rheumatoid arthritis: advances in treatment strategies. Mol Cell Biochem 478:69\u201388","journal-title":"Mol Cell Biochem"},{"key":"10290_CR104","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. The Lancet 389:2338\u20132348","journal-title":"The Lancet"},{"key":"10290_CR105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12010-022-04090-5","volume":"195","author":"X He","year":"2023","unstructured":"He X, Zhang C, Amirsaadat S, Jalil AT, Kadhim MM, Abasi M, Pilehvar Y (2023) Curcumin-loaded mesenchymal stem cell\u2013derived exosomes efficiently attenuate proliferation and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Appl Biochem Biotechnol 195:51\u201367","journal-title":"Appl Biochem Biotechnol"},{"key":"10290_CR106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/1756-185X.14021","volume":"24","author":"A Hejrati","year":"2021","unstructured":"Hejrati A, Hasani B, Esmaili M, Bashash D, Tavakolinia N, Zafari P (2021) Role of exosome in autoimmunity, with a particular emphasis on rheumatoid arthritis. Int J Rheum Dis 24:159\u2013169","journal-title":"Int J Rheum Dis"},{"key":"10290_CR107","first-page":"1907","volume":"23","author":"K Lin","year":"2019","unstructured":"Lin K, Su H, Jiang L, Chu T, Li Z, Chen X, Gao W (2019) Influences of miR-320a on proliferation and apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis through targeting MAPK-ERK1\/2. Eur Rev Med Pharmacol Sci 23:1907\u20131914","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10290_CR108","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia JM, Jover JA, Garc\u00eda-Vicu\u00f1a R, Carre\u00f1o L, Alonso A, Marsal S, Blanco F, Mart\u00ednez-Taboada VM, Taylor P, Mart\u00edn-Mart\u00edn C (2017) Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Ann Rheum Dis 76:196\u2013202","journal-title":"Ann Rheum Dis"},{"key":"10290_CR109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12717\/DR.2017.21.1.001","volume":"21","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Park J-S (2017) Usage of human mesenchymal stem cells in cell-based therapy: advantages and disadvantages. Develop Reprod 21:1","journal-title":"Develop Reprod"},{"key":"10290_CR110","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1159\/000494793","volume":"50","author":"L Wang","year":"2018","unstructured":"Wang L, Wang C, Jia X, Yu J (2018) Circulating exosomal miR-17 inhibits the induction of regulatory T cells via suppressing TGFBR II expression in rheumatoid arthritis. Cell Physiol Biochem 50:1754\u20131763","journal-title":"Cell Physiol Biochem"},{"key":"10290_CR111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201851","volume":"13","author":"Y Takamura","year":"2018","unstructured":"Takamura Y, Aoki W, Satomura A, Shibasaki S, Ueda M (2018) Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-\u03b1 stimulation. PLoS ONE 13:e0201851","journal-title":"PLoS ONE"},{"key":"10290_CR112","first-page":"2220566","volume":"34","author":"F Sun","year":"2023","unstructured":"Sun F, Ma Y, Li F, Li C, Yang Z (2023) Exosomes derived from berberine-treated bone marrow mesenchymal stem cells ameliorate inflammatory arthritis in rats with collagen-induced rheumatoid arthritis. Food Hydrocolloids 34:2220566","journal-title":"Food Hydrocolloids"},{"key":"10290_CR113","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","volume":"201","author":"Z Chen","year":"2018","unstructured":"Chen Z, Wang H, Xia Y, Yan F, Lu Y (2018) Therapeutic potential of mesenchymal cell\u2013derived miRNA-150-5p\u2013expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol 201:2472\u20132482","journal-title":"J Immunol"},{"key":"10290_CR114","doi-asserted-by":"crossref","first-page":"2979124","DOI":"10.1155\/2021\/2979124","volume":"2021","author":"K Jiang","year":"2021","unstructured":"Jiang K, Jiang T, Chen Y, Mao X (2021) Mesenchymal stem cell-derived exosomes modulate chondrocyte glutamine metabolism to alleviate osteoarthritis progression. Mediators Inflamm 2021:2979124","journal-title":"Mediators Inflamm"},{"key":"10290_CR115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2022.01.002","volume":"143","author":"Y Huang","year":"2022","unstructured":"Huang Y, Lu D, Ma W, Liu J, Ning Q, Tang F, Li L (2022) miR-223 in exosomes from bone marrow mesenchymal stem cells ameliorates rheumatoid arthritis via downregulation of NLRP3 expression in macrophages. Mol Immunol 143:68\u201376","journal-title":"Mol Immunol"},{"key":"10290_CR116","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ndt\/gfv270","volume":"31","author":"F Lang","year":"2016","unstructured":"Lang F, Pearce D (2016) Regulation of the epithelial Na+ channel by the mTORC2\/SGK1 pathway. Nephrol Dial Transplant 31:200\u2013205","journal-title":"Nephrol Dial Transplant"},{"key":"10290_CR117","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/1873-3468.14460","volume":"596","author":"Y Fu","year":"2022","unstructured":"Fu Y, Li J, Zhang Z, Ren F, Wang Y, Jia H, Liu Y, Chang Z (2022) Umbilical cord mesenchymal stem cell-derived exosomes alleviate collagen-induced arthritis by balancing the population of Th17 and regulatory T cells. FEBS Lett 596:2668\u20132677","journal-title":"FEBS Lett"},{"key":"10290_CR118","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.2147\/IJN.S333465","volume":"16","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang Y, Ma Y, Luo L, Chu M, Zhang Z (2021) Therapeutic potential of exosomal circRNA derived from synovial mesenchymal cells via targeting circEDIL3\/miR-485\u20133p\/PIAS3\/STAT3\/VEGF functional module in rheumatoid arthritis. Int J Nanomed 16:7977\u20137994","journal-title":"Int J Nanomed"},{"key":"10290_CR119","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102511","volume":"19","author":"F Tavasolian","year":"2020","unstructured":"Tavasolian F, Moghaddam AS, Rohani F, Abdollahi E, Janzamin E, Momtazi-Borojeni AA, Moallem SA, Jamialahmadi T, Sahebkar A (2020) Exosomes: Effectual players in rheumatoid arthritis. Autoimmun Rev 19:102511","journal-title":"Autoimmun Rev"},{"key":"10290_CR120","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.3390\/ijms22179543","volume":"22","author":"N Ku\u010duk","year":"2021","unstructured":"Ku\u010duk N, Primo\u017ei\u010d M, Knez \u017d, Leitgeb M (2021) Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers. Int J Mol Sci 22:9543","journal-title":"Int J Mol Sci"},{"key":"10290_CR121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15283\/ijsc19108","volume":"13","author":"H Baharlooi","year":"2020","unstructured":"Baharlooi H, Azimi M, Salehi Z, Izad M (2020) Mesenchymal stem cell-derived exosomes: a promising therapeutic ace card to address autoimmune diseases. Int J Stem Cells 13:13\u201323","journal-title":"Int J Stem Cells"},{"key":"10290_CR122","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13287-023-03295-7","volume":"14","author":"X Zhu","year":"2023","unstructured":"Zhu X, Ma D, Yang B, An Q, Zhao J, Gao X, Zhang L (2023) Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune\/inflammatory diseases. Stem Cell Res Ther 14:71","journal-title":"Stem Cell Res Ther"},{"key":"10290_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10:1\u201322","journal-title":"Stem Cell Res Ther"},{"key":"10290_CR124","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fphys.2020.00441","volume":"11","author":"Q Meng","year":"2020","unstructured":"Meng Q, Qiu B (2020) Exosomal microRNA-320a derived from mesenchymal stem cells regulates rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing CXCL9 expression. Front Physiol 11:441","journal-title":"Front Physiol"},{"key":"10290_CR125","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.2147\/JIR.S336099","volume":"14","author":"L Chang","year":"2021","unstructured":"Chang L, Kan L (2021) Mesenchymal stem cell\u2013originated exosomal circular RNA circFBXW7 attenuates cell proliferation, migration and inflammation of fibroblast-like synoviocytes by targeting miR-216a-3p\/HDAC4 in rheumatoid arthritis. J Inflamm Res 14:6157","journal-title":"J Inflamm Res"},{"key":"10290_CR126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-019-3017-y","volume":"21","author":"H-Y Meng","year":"2020","unstructured":"Meng H-Y, Chen L-Q, Chen L-H (2020) The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell. BMC Musculoskelet Disord 21:1\u201310","journal-title":"BMC Musculoskelet Disord"},{"key":"10290_CR127","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.2147\/IJN.S333465","volume":"16","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang Y, Ma Y, Luo L, Chu M, Zhang Z (2021) Therapeutic potential of exosomal circRNA derived from synovial mesenchymal cells via targeting circEDIL3\/miR-485-3p\/PIAS3\/STAT3\/VEGF functional module in rheumatoid arthritis. Int J Nanomed 16:7977","journal-title":"Int J Nanomed"},{"key":"10290_CR128","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2174\/1570159X19666210203161559","volume":"19","author":"T Yu","year":"2021","unstructured":"Yu T, Xu Y, Ahmad MA, Javed R, Hagiwara H, Tian X (2021) Exosomes as a promising therapeutic strategy for peripheral nerve injury. Curr Neuropharmacol 19:2141","journal-title":"Curr Neuropharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10290-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:25:18Z","timestamp":1766852718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10290-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10290"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10290-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}